$NBIO - announces that it is embarking on a fresh manufacturing run to ensure Pritumumab ("PTB"
supplies are at maximum potency when patient dosing begins in the upcoming Phase II clinical trial.
https://finance.yahoo.com/news/nascent-prepar...00620.html